Related Experiment Videos
Identification of four novel splice site mutations in the ornithine transcarbamylase gene
E Oppliger Leibundgut1, B Wermuth, J P Colombo
1Department of Clinical Chemistry, Inselspital, University of Berne, Switzerland.
Abstract:
Ornithine transcarbamylase (OTC) deficiency, the most common inborn error of the urea cycle, shows X-linked inheritance with frequent new mutations. Using polymerase chain reaction (PCR) amplification of the individual exons including adjacent intron sequences followed by direct sequencing of the amplimers we identified four new mutations affecting donor splice sites of introns 2, 5, 6, and 8. The mutation at the first position of intron 2 was a G to A exchange associated with acute neonatal hyperammonemia in a male patient at the age of 5 months. A G to C substitution in intron 5 was detected in a boy who developed 2 days after birth hypotonia, and respiratory distress, followed by severe hyperammonemia and terminal coma. The intron 6 mutation, a G to T substitution, was detected in a girl presenting with first episodes of vomiting and agitation at the age of 2 months. The mutation in intron 8, also a G to T transition, caused fatal hyperammonemia and early death at the age of 15 days in a male patient. We present four donor splice site mutations resulting in severe neonatal or very early onset of the disease in three boys and in one female patient. As the GT dinucleotide of the 5' donor splice site is invariant and required for correct splicing the described mutations may lead to improperly spliced mRNAs and aberrant gene products.
Insights
Four new mutations in the ornithine transcarbamylase (OTC) gene were identified, causing severe urea cycle disorder. These genetic changes affect crucial splice sites, leading to early-onset disease in infants.
Area of Science:
- Genetics
- Biochemistry
- Pediatrics
Background:
- Ornithine transcarbamylase (OTC) deficiency is the most common urea cycle disorder.
- It exhibits X-linked inheritance with a high rate of new mutations.
Purpose of the Study:
- To identify novel mutations causing OTC deficiency.
- To investigate the impact of these mutations on disease presentation and severity.
Main Methods:
- Polymerase chain reaction (PCR) amplification of OTC gene exons and adjacent introns.
- Direct sequencing of amplified DNA segments.
Main Results:
- Four new mutations affecting donor splice sites in introns 2, 5, 6, and 8 of the OTC gene were identified.
- These mutations were associated with severe neonatal or early-onset hyperammonemia in three male and one female patients.
- Specific mutations included G to A (intron 2), G to C (intron 5), and G to T (introns 6 and 8) exchanges.
Conclusions:
- The identified splice site mutations disrupt proper mRNA splicing, leading to aberrant OTC gene products.
- These mutations result in severe clinical manifestations of OTC deficiency, often with fatal outcomes in early infancy.